Price T Rowe Associates Inc Terns Pharmaceuticals, Inc. Transaction History
Price T Rowe Associates Inc
- $867 Billion
- Q4 2024
A detailed history of Price T Rowe Associates Inc transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,504,238 shares of TERN stock, worth $6.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,504,238
Previous 1,475,679
1.94%
Holding current value
$6.27 Million
Previous $12.3 Million
32.28%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
About Terns Pharmaceuticals, Inc.
- Ticker TERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,613,800
- Market Cap $157M
- Description
- Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...